These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39287044)

  • 1. Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer.
    Li J; Wu Y; Li Y; Zhu H; Zhang Z; Li Y
    ACS Nano; 2024 Oct; 18(39):26585-26599. PubMed ID: 39287044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
    Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
    J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy.
    Yang F; Xiao Y; Ding JH; Jin X; Ma D; Li DQ; Shi JX; Huang W; Wang YP; Jiang YZ; Shao ZM
    Cell Metab; 2023 Jan; 35(1):84-100.e8. PubMed ID: 36257316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diselenide-Containing Polymer Based on New Antitumor Mechanism as Efficient GSH Depletion Agent for Ferroptosis Therapy.
    Zhou C; Zhao Y; Yang M; Yin W; Li Y; Xiao Y; Liu Y; Lang M
    Adv Healthc Mater; 2024 Jul; 13(17):e2303896. PubMed ID: 38551494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTGER3 knockdown inhibits the vulnerability of triple-negative breast cancer to ferroptosis.
    Wang S; Zhang Y; Zhang D; Meng J; Che N; Zhao X; Liu T
    Cancer Sci; 2024 Jun; 115(6):2067-2081. PubMed ID: 38566528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.
    Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P
    Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis as a promising targeted therapy for triple negative breast cancer.
    Mokhtarpour K; Razi S; Rezaei N
    Breast Cancer Res Treat; 2024 Oct; 207(3):497-513. PubMed ID: 38874688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of NO Donor-Aurovertin Hybrids as Dual Ferroptosis and Apoptosis Inducers for Treating Triple Negative Breast Cancer.
    Ma LF; Xu LL; Yuan LJ; Yang X; Wu R; Bao SM; Chen YL; Duan HL; Fang L; Zhao HJ; Zhan ZJ
    J Med Chem; 2024 Aug; 67(15):13089-13105. PubMed ID: 39044437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activity of deguelin identifies therapeutic targets for androgen receptor-positive breast cancer.
    Robles AJ; Cai S; Cichewicz RH; Mooberry SL
    Breast Cancer Res Treat; 2016 Jun; 157(3):475-88. PubMed ID: 27255535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer.
    Chen T; Leng J; Tan J; Zhao Y; Xie S; Zhao S; Yan X; Zhu L; Luo J; Kong L; Yin Y
    J Med Chem; 2023 Jul; 66(14):10036-10059. PubMed ID: 37452764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy.
    Li K; Lin C; Li M; Xu K; He Y; Mao Y; Lu L; Geng W; Li X; Luo Z; Cai K
    ACS Nano; 2022 Feb; 16(2):2381-2398. PubMed ID: 35041395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer.
    Asghar US; Barr AR; Cutts R; Beaney M; Babina I; Sampath D; Giltnane J; Lacap JA; Crocker L; Young A; Pearson A; Herrera-Abreu MT; Bakal C; Turner NC
    Clin Cancer Res; 2017 Sep; 23(18):5561-5572. PubMed ID: 28606920
    [No Abstract]   [Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of RSL3-based GPX4 degraders with hydrophobic tags.
    Ning Y; Zhu Z; Wang Y; Fan X; Wang J; Qian H; Qiu X; Wang Y
    Eur J Med Chem; 2024 Nov; 277():116719. PubMed ID: 39094276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.
    Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S
    Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
    Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
    Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
    Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
    Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boswellia carterii n-hexane extract suppresses breast cancer growth via induction of ferroptosis by downregulated GPX4 and upregulated transferrin.
    Xie J; Huang H; Wei X; Tan P; Ouyang L; Wang L; Liu D; Wang F; Wang Z; Tu P; Li J; Zha X; Hu Z
    Sci Rep; 2024 Jun; 14(1):14307. PubMed ID: 38906931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis.
    Ming T; Lei J; Peng Y; Wang M; Liang Y; Tang S; Tao Q; Wang M; Tang X; He Z; Liu X; Xu H
    Phytother Res; 2024 Aug; 38(8):3954-3972. PubMed ID: 38837315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting PAX8 sensitizes ovarian cancer cells to ferroptosis by inhibiting glutathione synthesis.
    Luo Y; Liu X; Chen Y; Tang Q; He C; Ding X; Hu J; Cai Z; Li X; Qiao H; Zou Z
    Apoptosis; 2024 Oct; 29(9-10):1499-1514. PubMed ID: 38853202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.
    Lehmann BD; Bauer JA; Schafer JM; Pendleton CS; Tang L; Johnson KC; Chen X; Balko JM; Gómez H; Arteaga CL; Mills GB; Sanders ME; Pietenpol JA
    Breast Cancer Res; 2014 Aug; 16(4):406. PubMed ID: 25103565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.